Geron GERN
NASDAQ GERN
$1.16 -0.08 (-6.45%)
At close: Oct 21, 2026 · 4:00 PM EDT

Geron (GERN) Current Deferred Revenue (2010 - 2015)

Updated

Geron's Current Deferred Revenue came in at $35 million for Q2 2015, unchanged from the prior quarter.

Analysis

Geron (GERN) Current Deferred Revenue (2010 - 2015) Analysis & Trends

Going back to Q4 2010, Geron's Current Deferred Revenue data covers 4 quarters.

  • Current Deferred Revenue carries a four-year compound annual growth rate of 216.2% (FY2010 to FY2014).
  • Going back by year, Current Deferred Revenue was $350,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Geron 763.84 Mn -587.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 35.00 Mn
Mar 31, 2015 35.00 Mn
Dec 31, 2014 35.00 Mn
Dec 31, 2010 350,000.00
API Access

Geron Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GERN&period=max&api_key=YOUR_API_KEY